1-5 of 5
Guy Cantin
Close
Sort by
Journal Articles

Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

Andree-Anne Pelland, Xavier Savard, Frederic Barabe, Vincent Laroche, Michaël Munger, Genevieve Gallagher, Nicolas Marcoux, Guy Cantin, Maxime Chénard-Poirier, Robert Delage, Marc Lalancette, Christopher Lemieux
Journal: Blood
Blood (2022) 140 (Supplement 1): 3304–3305.
https://doi.org/10.1182/blood-2022-170223
Published: 2022
Journal Articles

Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study

Veronique Leblond, Guy Cantin, MD, Agostino Cortelezzi, Prof, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, MD, Andrey Zaritskey, Jean-Louis Merot, Kerstin Trunzer, Susan Robson, Ekaterina Gresko, Stephan Stilgenbauer, MD PhD, Robin Foà, Francesc Bosch
Journal: Blood
Blood (2017) 130 (Supplement 1): 3015.
https://doi.org/10.1182/blood.V130.Suppl_1.3015.3015
Published: 2017
Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5530.
https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530
Published: 2017
Journal Articles

A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial

Clinical Trials & Observations
A. Keith Stewart, Suzanne Trudel, Nizar J. Bahlis, Darrell White, Waleed Sabry, Andrew Belch, Tony Reiman, Jean Roy, Chaim Shustik, Michael J. Kovacs, Morel Rubinger, Guy Cantin, Kevin Song, Kirsty A. Tompkins, Deb C. Marcellus, Martha Q. Lacy, Jonathan Sussman, Donna Reece, Michael Brundage, Erica L. Harnett, Lois Shepherd, Judy-Anne W. Chapman, Ralph M. Meyer
Journal: Blood
Blood (2013) 121 (9): 1517–1523.
https://doi.org/10.1182/blood-2012-09-451872
Published: 2013
Journal Articles

Bortezomib Added to CVP-R Is Safe and Effective for Previously Untreated Advanced Stage Follicular Lymphoma: A Phase II Study by the NCIC Clinical Trials Group.

Laurie H. Sehn, MD, MPH, David A Macdonald, MD, Sheldon H. Rubin, MD, Guy Cantin, MD, Morel Rubinger, MD, Bernard Lemieux, MD, Sanraj Basi, MD, Kevin R Imrie, MD, Randy D. Gascoyne, Bingshu Chen, PhD, Marina Djurfeldt, MSc, Lois Shepherd, MD, Stephen Couban, MD, Michael Crump, MD
Journal: Blood
Blood (2009) 114 (22): 407.
https://doi.org/10.1182/blood.V114.22.407.407
Published: 2009